Female vaginal suppositories SCHALI®-FC

Instructions for Use
Personal Prophylactic Hygiene Care
Female Vaginal Suppositories
SCHALI^® Care–FC
Adjuvant Oncogynaecology

SCHALI^® Care–FC Vaginal Suppositories are a female personal care hygiene product intended for treatment of vaginal mucosa in adjuvant cancer therapy, after gynaecological surgery and in postsurgical rehabilitation for better regeneration, antibacterial and antimicrobial protection.

PRODUCT FORM:

Lubricating prophylactic suppositories, 2g.

INGREDIENTS:

The product contains environmental friendly biocompatible ingredients of plant and mineral origin.

Cocoa butter, Bee glue, Chelidoni herba leaves extract, Camelliae Sinensis non fermentata folia extract, Shilajit, Griffoinia simplicifolia seed extract, Titanium dioxide.

MECHANISM OF ACTION:

Based on natural plant oils and butters, minerals and phytoextracts, the product dissolves slowly in the vagina, where it is absorbed by vaginal mucosa and exerts anti-inflammatory and regenerating effects. The product acts locally by strengthening vascular walls and improving microcirculation in capillaries. Plant and mineral ingredients and their constituents act as free radicals scavengers, also reduce inflammatory reactions, trigger both spontaneous and induced synthesis of cytokines, inhibit oxidative stress, and prevent accumulation of lipid peroxidation products, enhancing in this way mechanisms of cellular antioxidant defence.

Mechanism of action is related to cellular suppression of the inducing effect of female sex hormones, activation of all factors of both specific and non-specific defence system against foreign agents, i.e. antigens.

Celandine may induce non-specific immune reactions and restore suppressed immunity, strengthen natural resistance, increase phagocytosis and efficiency of T- and B- immune cells, resulting in a quick relief of spasm, antibacterial and disinfecting effects. Celandine also increases number of secretory immunoglobulins sIgA, regulates IgE, restores endogenous interferon system, and induces function of human immune system by triggering phagocytosis in macrophages, cellular and humoral immune responses.

Griffonia simplicifolia induces female endocrine system, affects non-specific reactivity, and regulates metabolism. Adaptogenic effect results in better resistance against physical and psychoemotional stress.

Titanium dioxide induces vaginal epithelium cells to resist multiple infection and inflammation agents and in this way may prevent recurrent infection.

The product is intended for personal care purposes, has preventive action and may be used as a complex therapy agent in treatment of a wide range of gynaecological conditions. The product covers up and softly assuages vaginal mucosa, protects mucosa against injuries, and accelerates cells regeneration. Regular use of the product may improve local moistening and smoothing, reduce unpleasant sensation and inflammation (itching, burning pains, irritation).

Hypoallergenic product.

INDICATIONS:

• Benign vaginal and vulvar conditions
• Precancerous conditions in vulva
• Malignant vaginal and vulvar conditions
• Vaginal cancer
• Malignant vulvar lesions
• Vulvar papillae
• Benign vaginal neoplasms
• Vulvar leucoplakia
• Bartholin's cyst

METHOD OF USE:

For vaginal use only.

Take the product out of the package with clean hands and insert, pointed end first, into the vagina. With your finger put the suppository gently forward. Apply one suppository 2 times a day for one month. Extend your course of treatment up to 90 days, if necessary.

SIDE EFFECTS:

No side effects found.
No product dependence and no rebound syndrome.

CONTRAINDICATIONS:

Do not use during pregnancy.
No other contraindications detected.

STORAGE CONDITIONS:

Keep the product in a dark cool place at the temperature between +4^°С and 15^°С.

SHELF LIFE:

Shelf life is 2 years from the date of production.
Do not use the product after expiration of the date of production, specified on the package

SCHALI^® Care Personal Hygiene Products are made under license No. 286-S.